Neurology Today by Conference Series: Enlightening the New Scope in the Field of Neurology
SINGAPORE and LONDON (PRWEB) November 06, 2018 -- Neurology has emerged as an important field of study as it is aimed at treating the organs associated with the brain. Almost 600 disorders, such as Alzheimer’s disease, Epilepsy, Parkinson's disease, Stroke, and brain tumors etc., are known to affect the brain. Innovative approaches involving strong partnerships must be put in place in order to reduce the impact of neurological disorders. The USA and the UK are at the forefront of Neurology research.
These are interesting times for neuroscience R&D as there is an increased awareness of the socio-economic impact of psychiatric and neurodegenerative disorders on public health. Whilst there is an increased pressure on our limited health resources, the demand for affordable treatments to manage these diseases is escalating. Over the past few years, significant milestones in our understanding of neuropathology have been achieved, but there is still a long way to go when it comes to identification of the cause, treatment and prevention.
Identification and validation of molecular targets is extremely difficult in this field, making pharmacological development a time consuming process, with success rates as low as 8%. These make neurology one of the costliest therapeutic areas for R&D, with over $1.3 billion being required for the development of a single new molecular entity. Neuroscience is a potential hotbed for innovation, but there’s a warranted caution with respect to the pipeline investment. Although the prospective revenue from a single successful product would certainly exceed the cost to market, the risk is still very high. As of today, Neurology represents the largest, untapped market in pharmaceutical medicines sector.
The global neuroscience market was valued at around USD 26,350 million in the year 2016 and it is expected to reach approximately USD 34,800 million by 2024. CAGR of global neuroscience market is also expected to reach more than 3.5% between 2017 and 2024.
Neurology meetings held by the Conference Series provide the latest information in neurology and healthcare by organizing medical and healthcare meetings across America, Europe and Asia in collaboration with 1000+ scientific societies. These events gather renowned researchers, physicians and other healthcare professionals on a single platform to share their novel ideas that can catalyze innovations for treating neural disorders which in turn benefits the human health.
These conferences focus on addressing key topics, such as neurological disorders, neurodegenerative disorders, psychiatric disorders, neuromuscular disorders etc., along with other related topics, such as neurosurgery, neuroimaging and radiology, neuropharmacology, neuropsychiatry, neurogenetics, clinical neurology, pediatric neurology, and many more.
Our Neurology conferences not only generate awareness about the neurological disorders but also provide solutions for many diseases which are not preventable.
Many budding young scientists are interested in showcasing their research and these conferences are a stepping stone for these researchers. Dr. Srinubabu Gedela, CEO of Omics International dubbed these conferences as perfect platforms for fostering collaborations across industry and academia.
Scientific events organized by the Conference Series specifically aim to bring about a new spin in neurology by showcasing the latest scientific findings. Conference attendees earn CPD and CME credits which help to boost the participants’ careers. Students participating in these conferences are encouraged to participate in the poster secession and give presentations; they also get information about their job prospects and the latest job openings.
The Neurology Conferences 2019 are aimed at provoking discussions about important topics in neurology, such as neuroimmunology, sleep disorders, neuro-oncology, brain imaging, and neurophysiology.
Conference Series welcomes one and all to come participate and enrich the field of neurology.
Abhishek Babu, PULSUS GROUP, http://www.pulsus.com, +91 4047482201, [email protected]
Share this article